Department of Radiation Oncology
Division of Molecular Radiobiology
| Faculty
Adam Dicker, M.D., Ph.D. – Professor, Chairman and Director, Experimental Radiation Oncology Division Dennis B. Leeper, Ph.D. – Professor and Founding Director Ronald A. Coss, Ph.D. – Professor Ullrich Rodeck, M.D. – Professor of Dermatology Phyllis R. Wachsberger, Ph.D. – Assistant Professor Richard Lawrence, M.D. – Assistant Professor Qing Ren, M.D., Ph.D. – Instructor Adjunct Faculty George Iliakis, Ph.D. – Professor, University of Essen, DL Andrew J. Milligan, Jr., Ph.D. – Professor, President of Bionix Medical Technologies Ya Wang, M.D., Ph.D. – Professor, Emory University Randy Burd, Ph.D. – Assistant Professor, University of Arizona |
The Division of Molecular Radiobiology conducts molecular and translational radiobiological and hyperthermia research in conjunction with clinical research performed in the Department of Radiation Oncology. It is a critical component of the Radiation Research & Translational Biology Program of the Kimmel Cancer Center lead by Dr. Adam Dicker.
The division has a rich history, having been formed by Simon Kramer, under the leadership of Dennis Leeper. Currently, a successful xenograft laboratory is led by Dr. Phyllis Wachsberger. There is a strong basic science relationship with Dr. Ullrich Rodeck, based upon use of the zebrafish as a high throughput vertebrate model for the stress response. Research is supported by grants from the National Cancer Institute, Department of Defense, private foundations and pharmaceutical companies. In addition to basic research, annual didactic lectures and courses are provided for radiation oncology residents, medical and graduate students and staff. A visiting lecture series is conducted for the entire department.
We are in the process of transforming into a new Division of ‘Molecular and Translational Radiation Oncology’. This innovative division will focus on optimizing the combination of ionizing radiation with molecular targeted therapies. The new division will be led by a group of dedicated, talented individuals, with both scientific and clinical knowledge who can breach traditional academic boundaries.
